Natural Treatment has an Antibiotic-Like Effect on Viruses; CBCD Reports Publication of a new Clinical Study of Gene-Eden-VIR/Novirin

VALLEY COTTAGE, N.Y., May 8, 2017 /PRNewswire/ -- Most drugs target symptoms.  Antibiotics are different.  Antibiotics target the cause of the disease, and as a result, cure the disease.  Almost all other drugs, such as those that lower cholesterol or blood pressure, target symptoms.  These drugs don't cure the disease.  They reduce symptoms, for a while.  But because of their short term effect, patients need to take them again and again, for life.  Unlike these drugs, patients take antibiotics for a limited time, and clear the infection.  The effect of antibiotics is so remarkable, that Dr. Friedman and Dr. Friedland list antibiotics as one of "Medicine's 10 Greatest Discoveries."  Now, the Center for the Biology of Chronic Disease (CBCD) announces the publication of a clinical study that shows that Gene-Eden-VIR/Novirin has an antibiotic-like effect on viruses.

Antibiotics completely clear the bacteria in infected individuals.  The published clinical study shows that, amazingly, Gene-Eden-VIR/Novirin, like antibiotics, completely clears the human papillomavirus (HPV) in infected individuals.  After 12 months treatment, 100% of the participants in the study were HPV free vs. only 53%, 52%, 65%, 20%, and 77% in the five untreated groups.  In other words, within a year, Gene-Eden-VIR/Novirin completely wiped out the virus!  In contrast, 23%-80% of the untreated participants were still infected.  Currently, there are no treatments that get rid of latent viruses, and specifically, the latent human papillomavirus (HPV).  Gene-Eden-VIR/Novirin is the first of its kind.

The study was published in the leading peer-reviewed medical journal Drug Design, Development and Therapy (1).  The paper is available at: https://www.dovepress.com/human-papillomavirus-hpv-systemic-treatment-with-gene-eden-virnovirin--peer-reviewed-article-DDDT.  The paper is indexed on Pubmed.com.  The study is also explained in a video with Dr. Hanan Polansky and Dr. Edan Itzkovitz, see https://youtu.be/Rltv7zFvX-0.

According to Dr. Hanan Polansky, the lead author of the study, "When I first saw the results, I was shocked.  Doctors tell you that it is impossible to get rid of a latent virus.  Once you are infected, you are infected for life.  Well, our results say: 'Hold on a second!  This universal belief is wrong.'  Our study shows that there is a way to get rid of a latent virus!"

Gene-Eden-VIR/Novirin consists of five natural ingredients, quercetin, green tea extract, cinnamon extract, licorice extract, and selenium.  The Gene-Eden-VIR/Novirin formula is patent protected.  The formula was developed to target latent (hidden) viruses.  Two previous clinical studies showed that Gene-Eden-VIR/Novirin is effective against genital herpes (2) (3, and that it has antiviral properties (4).

In summary, the new paper reports the results of a clinical study that tested the effect of oral treatment with Gene-Eden-VIR/Novirin on the human papillomavirus (HPV).  The study showed that Gene-Eden-VIR/Novirin has an antibiotic-like effect on viruses.

(1)  Polansky H, Itzkovitz E, Javaherian A. Human papillomavirus (HPV): systemic treatment with Gene-Eden-VIR/Novirin safely and effectively clears virus. Drug Des Devel Ther. 2017 March 3, 11: 575—583;10:2713-22

(2)  Polansky H, Itzkovitz E, Javaherian A. Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases. Clin Transl Med. 2016 Dec;5(1):40.

(3)  Polansky, H. Javaherian, A. Itzkovitz E. Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and Famciclovir. Drug Design, Development and Therapy 2016:10 2713-2722

(4)  Polansky H, Itzkovitz E. Gene-Eden-VIR is antiviral: results of a post marketing clinical study. Pharmacol Pharm. 2013;4(6A):1-8

Media contact:

Mike Davis

585-250-9999

SOURCE The Center for the Biology of Chronic Disease

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED